Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)

Canalblog

Suivre ce blog

Administration + Créer mon blog

Publicité

24 septembre 2015

NEW PUBLICATIONS UPTO SEPTEMBER 18TH 2015

NEW PUBLICATIONS UPTO SEPTEMBER 18TH 2015

NEW PUBLICATIONS UPTO SEPTEMBER 18TH 2015 The effects of long-term topical glaucoma medication on conjunctival i Long-term use of topical drugs can induce changes in theconjunctiva and ocular surface. To determine theconjunctival changes resulting from...

Posté par Eric Belot à 22:26 - Commentaires […] - Permalien [#]

Tags: publications, Dry eye, DED, New Therapies, News, artificial tears, cyclosporin, pain

Partager cet article

Vous aimez ?

0 vote

Publicité

Publicité

18 septembre 2015

NEW PUBLICATIONS UPTO SEPTEMBER 13TH 2015

NEW PUBLICATIONS UPTO SEPTEMBER 13TH 2015

NEW PUBLICATIONS UPTO SEPTEMBER 13TH 2015 Put the Squeeze on Meibomian Gland Disease Meibomian gland dysfunction (MGD) can lead to inflammation of the meibomian glands (meibomianitis) and excess oil in the tear film. Bacteria and other substances often...

Posté par Eric Belot à 19:51 - Commentaires […] - Permalien [#]

Tags: publications, Meibomian, glands, Tarsal glands Meibomius glands dysfunction, Dry eye, treatment, DED, 2015, Optometrist, News, Sjögren's syndrome, doxycycline

Partager cet article

Vous aimez ?

0 vote

9 septembre 2015

Strong efficacy of LipiFlow demonstrated across 31 peer-reviewed reports

Strong efficacy of LipiFlow demonstrated across 31 peer-reviewed reports

Strong efficacy of LipiFlow demonstrated across 31 peer-reviewed reports Long-term efficacy of a single LipiFlow procedure evaluated and reported in both sponsored and independent studies MORRISVILLE, N.C. ─ September 8, 2015 ─ TearScience , a privately...

Posté par Eric Belot à 15:32 - Commentaires […] - Permalien [#]

Tags: publications, Meibomian, Lipidflow, Tearscience website, Dry eye, DED, 2015

Partager cet article

Vous aimez ?

0 vote

9 septembre 2015

NEUROPTIS BIOTECH TO SELL ML7 FOR R&D ACTIVITIES

NEUROPTIS BIOTECH TO SELL ML7 FOR R&D ACTIVITIES

NEUROPTIS IS THE OWNER OF PATENTS ON THE SYNTHESIS OF PURIFIED AND STABLE ML7 ACCORDING TO THE REQUIREMENTS OF EMEA AND FDA WITHOUT ANY DEGRADATION PRODUCT NEUROPTIS HAS ALSO DEVELOPED METHODS OF DOSAGE OF ML7 (HPLC) IN DIFFERENT BIOLOGICAL LIQUIDS NEUROPTIS...

Posté par Eric Belot à 15:24 - Commentaires […] - Permalien [#]

Tags: patents, ML7, formulation, Synthesis, MLCK inhibitor, Price

Partager cet article

Vous aimez ?

0 vote

7 septembre 2015

Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating MLCK Expression through Cross-talk with p38 MAPK

Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating MLCK Expression through Cross-talk with p38 MAPK

Asian Pac J Cancer Prev. 2015;16(14):5835-42. Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating Myosin Light Chain Kinase Expression through Cross-talk with p38 MAPK. Papers in the journal Asian Pacific Journal of Cancer Prevention:...

Posté par Eric Belot à 21:55 - Commentaires […] - Permalien [#]

Tags: ML7, MLCK inhibitor, Colon Cancer, Melatonin, Migration of cells

Partager cet article

Vous aimez ?

0 vote

Publicité

Publicité

Publicité

Publicité